Cord Blood Transplant
Showing 1 - 4 of 4
High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Hematological Malignancy
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
Seattle, WashingtonFred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022
High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))
Recruiting
- High Risk Myeloid Malignancies
- Cord Blood Transplant
- ECT-001-CB (UM171-Expanded Cord Blood Transplant)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 12, 2022
High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)
Recruiting
- High Risk Hematologic Malignancy
- Cord Blood Transplant
- Transplant with an expanded ECT-001 cord blood
-
Montréal, Quebec, CanadaCIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021
Cord Blood Transplant, Hematologic Malignancy, Inherited Metabolic Disease Trial in Durham (TXA127)
Withdrawn
- Cord Blood Transplant
- +2 more
-
Durham, North CarolinaPediatric Bone and Cord Blood, Duke Univ. Med. Center
Aug 29, 2016